We make medicines for some of the world’s most serious and life-threatening diseases, and protecting patient safety at each step of the supply chain is critical. We are committed to ensuring people can safely access our medicines when they need them.

Illegitimate medicines – medicines that may be counterfeit, adulterated, diverted or illegally imported - continue to pose a significant global threat to patient safety. These medicines are neither safe nor effective and have significant negative implications for public health. Several factors, such as technological advancements, globalization and the Internet, have enabled counterfeiters to more easily manufacture counterfeit goods and introduce illegitimate medicines into the supply chain.